Today: 19 July 2026
Rigetti Computing (RGTI) stock jumps 6.6% as insiders flag a proposed sale — what’s next for traders
3 January 2026
1 min read

Rigetti Computing (RGTI) stock jumps 6.6% as insiders flag a proposed sale — what’s next for traders

NEW YORK, January 3, 2026, 07:29 ET — Market closed

  • Rigetti shares jumped 6.5% to $23.60 in Friday’s session, with heavy trading volume.
  • A Form 144 notice flagged a proposed sale of 59,316 shares by director Alissa Fitzgerald, worth about $1.31 million.

Rigetti Computing Inc (RGTI) shares ended Friday up 6.6% at $23.60, with about 37.3 million shares traded.

The move put the quantum-computing developer back on traders’ screens at the start of a year expected to bring a steady flow of economic data and corporate earnings that can reset appetite for risk.

Quantum stocks have tended to trade more like sentiment gauges than cash-flow stories, swinging on expectations for interest rates and the speed at which the technology reaches commercial-scale workloads.

A Form 144 filing with the U.S. Securities and Exchange Commission listed board director Alissa Fitzgerald as the person for whose account shares may be sold.

The document showed up to 59,316 shares could be sold, with an aggregate market value of about $1.31 million.

It also cited March 13, 2025 as the adoption date for a Rule 10b5-1 plan, a pre-set trading instruction often used by executives and directors to schedule sales.

Rigetti traded between $21.62 and $24.01 on Friday after opening at $22.56, Zacks data showed.

The rally was not isolated: IonQ gained 4.3%, D-Wave Quantum rose 7.6% and Quantum Computing Inc climbed 7.3% on the day.

Before the next session, investors will be watching next Friday’s U.S. jobs report and a consumer price index reading due Jan. 13, with fourth-quarter earnings season also approaching, Reuters reported. “The market is looking for direction,” said Matthew Maley, chief market strategist at Miller Tabak. Reuters

For Rigetti, the next company-specific catalyst on most calendars is its quarterly report, expected around March 5.

Technically, the stock remains well below its 50-day moving average of $29.13 and far from its 52-week high of $58.15, while the 52-week low stands at $5.95, according to Yahoo Finance.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • CSL Recovers A$16 Billion in Value, Trails Plasma Sector Gains This Week
    July 19, 2026, 3:25 PM EDT. CSL Limited (ASX:CSL) finished July 17 at A$123.32, rising 1.12% on the session and 0.35% for the week, recovering 37% from its 52-week low at A$90 and regaining roughly A$16 billion in valuation. However, CSL underperformed plasma specialists Grifols SA (+1.95%) and Takeda Pharmaceutical (+2.26%) in weekly movement. Trading volume for CSL on Friday came in 14% under its average as 1.62 million shares changed hands. The full-year financial results are due August 18. Still 55% beneath its 52-week peak, CSL's market value stands at A$59.06 billion. The group forecasts FY26 revenues near US$15.2 billion and NPATA of about US$3.1 billion, while a US$5 billion impairment remains subject to audit and board sign-off.
UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead
Previous Story

UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

Blackbaud stock slides nearly 6% to start 2026 as investors eye jobs data and mid-Feb earnings window
Next Story

Blackbaud stock slides nearly 6% to start 2026 as investors eye jobs data and mid-Feb earnings window

Go toTop